Hidradenitis Secondary to Nirogacestat, a Recently Approved Desmoid Tumor Medication

    December 2024 in “ JAAD Case Reports ”
    Travis Frantz, David S Kirwin, Catherine Brahe
    Studysummary This review discusses previously reported cases of drug-associated hidradenitis suppurativa linked to various immunomodulating medications but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadcasereports.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Hidradenitis Suppurativa Secondary to Treatment With a Gamma Secretase Inhibitor JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2023